Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI

Podcast

Incidence, Treatment, and Outcomes of Coronary Artery Perforation During PCI: JIC Podcast Episode 2

11/07/2022

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Deepak Bhatt, MD, MPH, Editor-in-Chief of the Journal of Invasive Cardiology (JIC), and Emmanouil Brilakis discuss coronary perforation, a rare but potentially life-threatening complication of PCI.

Deepak Bhatt, MD, MPH,...

11/07/2022

Journal of Invasive Cardiology

Review

Pharmacoinvasive Management of Acute Coronary Syndrome in the Setting of Percutaneous Coronary Intervention: Evidence-Based, Sit

08/01/2008

James J. Ferguson III, MD;

James P. Zidar , MD;

Glenn N. Levine , MD;

James E. Tcheng , MD;

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Gideon Bosker , MD;

Gary L. Schaer , MD, FACC, FSCAI;

Dean J. Kereiakes , MD, FACC, FSCAI;

Jose G. Diez , MD;

Edward T.A. Fry , MD;

A total of 5,225 patients were enrolled in the PARAGON B trial. Among these patients, the type of heparin used was known in 5,200 (99.5%). The median duration of therapy was 72.8 hours for UFH and 79.7 hours for LMWH. LMWH was used in about...

A total of 5,225 patients were...

08/01/2008

Journal of Invasive Cardiology

The First DES Meta-Analysis: What do 14 studies and 6,675 total patients tell us about stent thrombosis?

06/19/2008

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Interview questions were formulated by members of the Cath Lab Digest Editorial Board.Has the meta-analysis told us anything about criteria to fall back on when choosing between a bare-metal stent and a drug-eluting stent? It was a study of...

Interview questions were...

06/19/2008

Cath Lab Digest

Editor's Message

Further Evolution of the Journal of Invasive Cardiology

01/06/2014

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

01/06/2014

Journal of Invasive Cardiology

Feature

Case Presentations and Discussions (Cases 3 and 4)

08/01/2008

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Jeffrey J. Popma , MD, FACC, FSCAI;

CASE #3 Jeffrey Popma, MD Let me begin by talking about our new catheterization laboratory table that accommodate patients up to 600 lbs. Everyone should get one of these tables because it will allow you to receive some incredible patient...

CASE #3 Jeffrey Popma, MD Let...

08/01/2008

Journal of Invasive Cardiology

Video

An Upfront RotaTripsy Strategy for the Treatment of De Novo and In-Stent Restenosis Cases

03/09/2023

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Samin K. Sharma , MD, FACC, FSCAI;

In this episode, Dr Deepak Bhatt, JIC Editor-in-Chief interviews Dr Samin Sharma about his recent paper. "Efficacy and Safety of an Upfront RotaTripsy Strategy in the Treatment of De Novo and In-Stent Restenosis Cases."

In this episode, Dr Deepak...

03/09/2023

Journal of Invasive Cardiology

Editor's Message

August 2012: The Increasing International Presence of the Journal of Invasive Cardiology

07/30/2012

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Interventional cardiology continues to grow worldwide. In part, this is due to the effectiveness of the procedures and the relative cost-effectiveness of interventional approaches versus surgical approaches. Innovation in procedural aspects,...

Interventional cardiology...

07/30/2012

Journal of Invasive Cardiology

Commentary

Breaking with Tradition: Is Diagnostic Angiography Really
Necessary before Primary PCI?

08/01/2008

Adnan K. Chhatriwalla , MD;

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

The superiority of primary percutaneous coronary intervention (PCI) over fibrinolytic therapy for the treatment of ST-elevation myocardial infarction (STEMI) has been demonstrated in several large studies.1-3 Nevertheless, the preponderance...

The superiority of primary...

08/01/2008

Journal of Invasive Cardiology

Editorial

COVID-19: An Unintended Force for Medical Revolution?

04/01/2020

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Xiaowen Wang , MD;

Our healthcare systems are facing unprecedented pressure to come up with innovative solutions to help combat coronavirus disease 2019.

Our healthcare systems are...

04/01/2020

Journal of Invasive Cardiology

Feature

Diffuse Coronary Disease and Atherothrombosis: A Rationale for Long-Term Therapy to Prevent Recurrent Ischemic Events

08/01/2008

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

When examining the diffuse nature of coronary disease, it is important to recognize the fact that acute coronary syndromes are just the tip of the atherothrombotic “iceberg” (Figure 1). That is, they are the events which are clinically...

When examining the diffuse...

08/01/2008

Journal of Invasive Cardiology